BioSpace News Archive

Drug Development

Palleon Pharmaceuticals Announces First Patient Dosed with E-602 in Combination with Cemiplimab in GLIMMER-01 Phase 1/2 Clinical Trial

Palleon Pharmaceuticals today announced that the first patient has been dosed in the combination therapy cohort of the Phase 1/2 clinical trial for E-602, its lead candidate from the EAGLE (Enzyme Antibody Glyco-Ligand Editing) oncology platform.

June 22, 2023
·
2 min read
Biotech Beach

RayzeBio to Present at Society of Nuclear Medicine and Molecular Imaging Annual Meeting

RayzeBio, Inc. today announced that the Company will be presenting dosimetry data for its lead clinical program, RYZ101 (Ac225 DOTATATE) at the annual meeting of Society of Nuclear Medicine and Molecular Imaging (SNMMI), being held from June 24 - 27, 2023 at McCormick Place, Chicago, Illinois.

June 22, 2023
·
1 min read
Pharm Country

BTG Pharmaceuticals Statement on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommendation for Use of Glucarpidase (Voraxaze®) and MTXPK.org

BTG Pharmaceuticals, a SERB company, highlights the recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for Acute Lymphoblastic Leukemia, B-Cell Lymphomas, Pediatric Acute Lymphoblastic Leukemia, and Pediatric Aggressive Mature B-Cell Lymphomas.

June 22, 2023
·
7 min read
BioMidwest

Excite Medical Unveils DRX9000 Spinal Decompression Marketing Workshop Dates

Excite Medical, the manufacturer of the revolutionary DRX9000™ spinal decompression machine, is announcing two new dates for their Spinal Decompression Marketing Workshop in Tampa, FL.

June 22, 2023
·
2 min read
Business

Promore Pharma Reduces Costs and Explores the Conditions for a Reverse Acquisition

Promore Pharma (STO:PROMO)(FRA:8T0) STOCKHOLM, June 22, 2023 -- Promore Pharma AB comments today that a number of measures have been taken to reduce the Company’s costs, which includes the discontinuation of the ensereptide project and the termination of the Company’s key personnel.

June 22, 2023
·
3 min read
Genetown

Microbot Medical Expand IP protection in Japan

Microbot Medical Inc. announced the expansion of its global IP portfolio by receiving a Grant of Protection from the Japan Patent Office for a Design Patent covering the innovative industrial design of the robotic drive of the LIBERTY Robotic Surgical System.

June 22, 2023
·
3 min read
Business

Accumulus Synergy Appoints Jacques Mascaro as Chair of the Board

Accumulus Synergy, a nonprofit trade association working to address the global need for digital transformation within the life sciences - regulatory ecosystem, announced the appointment of Jacques Mascaro as the new Chair of the Board of Directors.

June 22, 2023
·
3 min read
Pharm Country

The Leukemia & Lymphoma Society Launches New Study to Test Shorter Treatment Cycle for Deadly Form of Leukemia

The Leukemia & Lymphoma Society announced that the first patient was dosed in a clinical trial investigating whether a shorter course of combination therapy is less toxic while remaining as effective as the FDA-approved regimen in older patients with newly diagnosed acute myeloid leukemia.

June 22, 2023
·
6 min read
Business

Acasti Announces Appointment of New Scientific Advisory Board Members

Acasti Pharma Inc. today announced the appointment of W. Taylor Kimberly , MD, PhD, Alejandro A. Rabinstein, MD and Sherry H-Y. Chou, MD to its Scientific Advisory Board.

June 22, 2023
·
9 min read
Business

Ansys Expands Presence to Africa with New Office in Rwanda

Ansys, the global leader and innovator of engineering simulation software, is establishing its first physical presence in Africa with a new office in Kigali, Rwanda.

June 22, 2023
·
3 min read